| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Li,Si-Ming | Chairman | 6.46% | |
| Luo,Xiang-Wei | Director | 2.37% | |
| Wu,Kai-Xing | Director | 11.77% | |
| Chen,Yu-Hong | Director | 3.28% | |
| Hong,Wen-Jun | Independent Director | 0.00% | |
| Lin,Guo-Ji | Independent Director | 0.00% | |
| Wang,Xiao-Wen | Independent Director | 0.00% |
Change Company Name to AIPASI BIOTECHNOLOGY CO., LTD. (FORMER NAME: AIPASI BIOTECHNOLOGY CO., LTD.)
2023/08/16
Change Company Name to A PLUS BIOTECHNOLOGY CO., LTD.
2023/08/16
Change Company Name to AIPASI BIOTECHNOLOGY CO., LTD. (FORMER NAME: AIPASI BIOTECHNOLOGY CO., LTD.)
2023/07/17
Change Company Name to A PLUS BIOTECHNOLOGY CO., LTD.
2023/07/17
Change Company Name to AIPASI BIOTECHNOLOGY CO., LTD. (FORMER NAME: AIPASI BIOTECHNOLOGY CO., LTD.)
2023/05/24
Change Company Name to A PLUS BIOTECHNOLOGY CO., LTD.
2023/05/24
Change Company Name to AIPASI BIOTECHNOLOGY CO., LTD. (FORMER NAME: AIPASI BIOTECHNOLOGY CO., LTD.)
2022/12/05
Change Company Name to A PLUS BIOTECHNOLOGY CO., LTD.
2022/12/05
Change Capital to 800,000,000
2022/12/05
Change Company Name to AIPASI BIOTECHNOLOGY CO., LTD. (FORMER NAME: AIPASI BIOTECHNOLOGY CO., LTD.)
2022/07/08
Change Company Name to A PLUS BIOTECHNOLOGY CO., LTD.
2022/07/08
Change Capital to 400,000,000
2014/09/16
Change Capital to 200,000,000
2014/01/02
Change Person in Charge to Li,Si-Ming
2013/04/29
Change Capital to 100,000,000
2012/06/29
Change Capital to 50,000,000
2011/11/24
Change Company Name to A PLUS BIOTECHNOLOGY CO., LTD.
2011/06/20
Change Capital to 20,720,000
2011/06/20
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 196,387 | 769,591 | 675,047 |
| Operating cost | 55,553 | 234,813 | 214,373 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 140,834 | 534,778 | 460,674 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 140,834 | 534,778 | 460,674 |
| Operating expenses | 87,505 | 352,319 | 293,134 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 53,329 | 182,459 | 167,540 |
| Non-operating income and expenses | 286 | 5,097 | -122,038 |
| Net profit (loss) before tax | 53,615 | 187,556 | 45,502 |
| Income tax expense (benefits) | 9,990 | 36,500 | 14,343 |
| Net profit (loss) of ongoing business for the current period | 43,625 | 151,056 | 31,159 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 43,625 | 151,056 | 31,159 |
| Other comprehensive profit (loss), net | 4,055 | 6,263 | -3,276 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 47,680 | 157,319 | 27,883 |
| Net profit (loss) attributable to owners of parent company | 43,625 | 151,056 | 31,159 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 47,680 | 157,319 | 27,883 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 1 | 4 | 1 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 51,771 | 160,956 | 159,104 |
| Net cash inflows (outflows) from investing activities | -3,702 | -39,045 | -4,849 |
| Net cash inflow (outflow) from financing activities | -3,064 | -80,489 | -69,179 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 1,332 | 480 | -3,697 |
| Increase (decrease) in cash and cash equivalents in the current period | 46,337 | 41,902 | 81,379 |
| Beginning balance of cash and cash equivalents | 360,968 | 319,066 | 237,687 |
| Ending balance of cash and cash equivalents | 407,305 | 360,968 | 319,066 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 946,564 | 896,849 | 769,575 |
| Non-current asset | 278,379 | 280,465 | 344,212 |
| Total asset | 1,224,943 | 1,177,314 | 1,113,787 |
| Current liability | 289,126 | 163,309 | 142,828 |
| Non-current liability | 90,976 | 94,960 | 100,552 |
| Total liability | 380,102 | 258,269 | 243,380 |
| share capital | 304,710 | 304,710 | 304,710 |
| Equity - secruity token | - | - | - |
| capital reserve | 307,679 | 307,679 | 360,006 |
| retained earning | 221,789 | 300,048 | 219,499 |
| Other equity | 10,663 | 6,608 | 345 |
| Treasury stock | 0 | 0 | -14,153 |
| Total equity attributable to owners of parent company | 844,841 | 919,045 | 870,407 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 844,841 | 919,045 | 870,407 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 288,000 |
| Net asset value per share | 27 | 30 | 28 |
